Jerry Gurwitz to New England
This is a "connection" page, showing publications Jerry Gurwitz has written about New England.
Connection Strength
0.341
-
Tjia J, Field TS, Garber LD, Donovan JL, Kanaan AO, Raebel MA, Zhao Y, Fuller JC, Gagne SJ, Fischer SH, Gurwitz JH. Development and pilot testing of guidelines to monitor high-risk medications in the ambulatory setting. Am J Manag Care. 2010 Jul; 16(7):489-96.
Score: 0.083
-
Willey CJ, Andrade SE, Cohen J, Fuller JC, Gurwitz JH. Polypharmacy with oral antidiabetic agents: an indicator of poor glycemic control. Am J Manag Care. 2006 Aug; 12(8):435-40.
Score: 0.064
-
Mazor KM, Simon SR, Yood RA, Martinson BC, Gunter MJ, Reed GW, Gurwitz JH. Health plan members' views on forgiving medical errors. Am J Manag Care. 2005 Jan; 11(1):49-52.
Score: 0.057
-
Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, Cadoret C, Fish LS, Garber L, Kelleher M, Bates DW. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003 Mar 05; 289(9):1107-16.
Score: 0.050
-
Fischer SH, Tjia J, Reed G, Peterson D, Gurwitz JH, Field TS. Factors associated with ordering laboratory monitoring of high-risk medications. J Gen Intern Med. 2014 Dec; 29(12):1589-98.
Score: 0.027
-
Fischer SH, Field TS, Gagne SJ, Mazor KM, Preusse P, Reed G, Peterson D, Gurwitz JH, Tjia J. Patient completion of laboratory tests to monitor medication therapy: a mixed-methods study. J Gen Intern Med. 2013 Apr; 28(4):513-21.
Score: 0.025
-
Saczynski JS, Lessard D, Spencer FA, Gurwitz JH, Gore JM, Yarzebski J, Goldberg RJ. Declining length of stay for patients hospitalized with AMI: impact on mortality and readmissions. Am J Med. 2010 Nov; 123(11):1007-15.
Score: 0.021
-
Field TS, Gurwitz JH, Harrold LR, Rothschild JM, Debellis K, Seger AC, Fish LS, Garber L, Kelleher M, Bates DW. Strategies for detecting adverse drug events among older persons in the ambulatory setting. J Am Med Inform Assoc. 2004 Nov-Dec; 11(6):492-8.
Score: 0.014